| scholarly article | Q13442814 |
| P50 | author | Giulia Murtas | Q54963175 |
| P2093 | author name string | Silvia Sacchi | |
| Pamela Cappelletti | |||
| P2860 | cites work | Immunocytochemical localization of D-amino acid oxidase in rat brain | Q58236646 |
| Ultrastructural localization of catalase and D-amino acid oxidase in 'normal' fetal mouse liver | Q69877210 | ||
| Localization of D-amino acid oxidase mRNA in the mouse kidney and the effect of testosterone treatment | Q70934129 | ||
| Proton release during the reductive half-reaction of D-amino acid oxidase | Q72532547 | ||
| Characterization of D-amino acid oxidase from Trigonopsis variabilis | Q72666242 | ||
| D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes | Q72788226 | ||
| Regulation of rat magnocellular neurosecretory system by D-aspartate: evidence for biological role(s) of a naturally occurring free D-amino acid in mammals | Q73131335 | ||
| Nephrotoxicity of D-proparglyglycine in mice | Q73245807 | ||
| Study on the decrease of renal d-amino acid oxidase activity in the rat after renal ischemia by chiral ligand exchange capillary electrophoresis | Q82620482 | ||
| Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance | Q87223869 | ||
| Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia | Q22241679 | ||
| d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia | Q24294371 | ||
| Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis | Q24297316 | ||
| Evidence for the interaction of D-amino acid oxidase with pLG72 in a glial cell line | Q24306641 | ||
| Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia | Q24308818 | ||
| Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment | Q24316880 | ||
| Characterization of human D-amino acid oxidase | Q24317569 | ||
| pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility | Q24320365 | ||
| The x-ray structure of D-amino acid oxidase at very high resolution identifies the chemical mechanism of flavin-dependent substrate dehydrogenation | Q27628036 | ||
| Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors | Q27655460 | ||
| Crystal structure of D-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2 | Q27733284 | ||
| WebLogo: A Sequence Logo Generator | Q27860646 | ||
| An Improved Drugs Screening System Reveals that Baicalein Ameliorates the Aβ/AMPA/NMDA-Induced Depolarization of Neurons | Q48348242 | ||
| Involvement of D-amino acid oxidase in elimination of D-serine in mouse brain | Q48444964 | ||
| Age-related effects of the neuromodulator D-serine on neurotransmission and synaptic potentiation in the CA1 hippocampal area of the rat. | Q48491445 | ||
| Distribution of D-amino acid oxidase (DAO) activity in the medulla and thoracic spinal cord of the rat: implications for a role for D-serine in autonomic function | Q48584609 | ||
| D-amino-acid oxidase is not present in the mouse liver | Q48727265 | ||
| Leucine Modulates Peptide Transport System-1 Across the Blood-brain Barrier at a Stereospecific Site within the Central Nervous System | Q48763585 | ||
| Regional distribution and postnatal changes of D-amino acids in rat brain | Q48763751 | ||
| Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase | Q48857138 | ||
| Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine. | Q48925158 | ||
| D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation. | Q50127100 | ||
| Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System. | Q50482411 | ||
| Elucidation of inhibitor-binding pockets of d-amino acid oxidase using docking simulation and N-sulfanylethylanilide-based labeling technology. | Q50998776 | ||
| CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS). | Q52430933 | ||
| Structure and function of D-amino acid oxidase. I. Further purification of hog kidney D-amino acid oxidase and its hydrodynamic and optical rotatory properties. | Q54189331 | ||
| The Role of Hydrogen Sulfide in Renal System | Q28066719 | ||
| D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia | Q28240880 | ||
| Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia | Q28274560 | ||
| Physiological functions of D-amino acid oxidases: from yeast to humans | Q28295729 | ||
| Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits | Q28570536 | ||
| A critical role for the glial-derived neuromodulator D-serine in the age-related deficits of cellular mechanisms of learning and memory | Q28571166 | ||
| Cellular and Molecular Mechanisms of Pain | Q29011961 | ||
| Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission in mutant mice lacking D-amino-acid oxidase | Q31680371 | ||
| The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. | Q33611796 | ||
| Activity of D-amino acid oxidase is widespread in the human central nervous system | Q33730910 | ||
| Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase | Q33842154 | ||
| Neurobiology through the looking-glass: D-serine as a new glial-derived transmitter | Q33960838 | ||
| Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. | Q33966453 | ||
| Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients | Q33987618 | ||
| D-amino acids in the central nervous system in health and disease | Q33988102 | ||
| Metabolism of amino-acids: Deamination of amino-acids | Q33996419 | ||
| Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 | ||
| Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). | Q33997506 | ||
| Why is D-serine nephrotoxic and alpha-aminoisobutyric acid protective? | Q34003528 | ||
| Mouse mutant deficient in D-amino acid oxidase activity | Q34005267 | ||
| D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration. | Q34012334 | ||
| Metabolism of the neuromodulator D-serine. | Q34021473 | ||
| The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review | Q34033121 | ||
| The NMDA receptor as a target for cognitive enhancement | Q34288139 | ||
| d-serine levels in Alzheimer's disease: implications for novel biomarker development | Q34475073 | ||
| Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways | Q35624305 | ||
| D-amino acid oxidase controls motoneuron degeneration through D-serine | Q35673702 | ||
| Homology Directed Knockin of Point Mutations in the Zebrafish tardbp and fus Genes in ALS Using the CRISPR/Cas9 System | Q35940756 | ||
| D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain | Q36025408 | ||
| The identification and characterization of excitotoxic nerve-endings in Alzheimer disease | Q36173238 | ||
| Molecular cloning and sequence analysis of cDNA encoding human kidney D-amino acid oxidase | Q36416313 | ||
| D-amino acid oxidase in leukocytes: a possible D-amino-acid-linked antimicrobial system | Q36450594 | ||
| Crystal structure of human D-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. | Q36458171 | ||
| D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity | Q46813951 | ||
| Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase | Q47117950 | ||
| Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons | Q47118571 | ||
| Human d-amino acid oxidase: The inactive G183R variant | Q47258168 | ||
| Improved purification, amino acid analysis and molecular weight of homogenous D-amino acid oxidase from pig kidney | Q47363347 | ||
| Biochemical Properties of Human D-Amino Acid Oxidase. | Q47868455 | ||
| Contribution of serine racemase/d-serine pathway to neuronal apoptosis. | Q47899065 | ||
| The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration | Q48101938 | ||
| Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease | Q48268722 | ||
| Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase | Q48305063 | ||
| Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain | Q48317594 | ||
| Novel targets for drugs in schizophrenia | Q36907403 | ||
| Human D-amino acid oxidase: an update and review. | Q36965925 | ||
| D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain | Q37118079 | ||
| Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota | Q37357830 | ||
| Central sensitization: a generator of pain hypersensitivity by central neural plasticity | Q37361185 | ||
| D-amino acid oxidase: physiological role and applications | Q37392938 | ||
| Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study | Q37420164 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| The C-terminal region of G72 increases D-amino acid oxidase activity | Q37535383 | ||
| Of mice and CRISPR: The post-CRISPR future of the mouse as a model system for the human condition. | Q37618027 | ||
| Hydrogen sulfide: advances in understanding human toxicity | Q37809419 | ||
| Serine racemase and the serine shuttle between neurons and astrocytes | Q37827616 | ||
| Structure-function relationships in human D-amino acid oxidase. | Q38032223 | ||
| NMDA receptors and memory encoding | Q38102828 | ||
| The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration. | Q38164385 | ||
| NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease | Q38177352 | ||
| D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone. | Q38672905 | ||
| G72 primate-specific gene: a still enigmatic element in psychiatric disorders | Q38749650 | ||
| Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs | Q38907627 | ||
| The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. | Q39062810 | ||
| Characterization of human DAAO variants potentially related to an increased risk of schizophrenia. | Q39230935 | ||
| Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction | Q39613722 | ||
| In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties | Q40097342 | ||
| Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies | Q41619176 | ||
| Involvement of D-amino acid oxidase in elimination of free D-amino acids in mice | Q41967195 | ||
| Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis | Q42481724 | ||
| A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. | Q42856729 | ||
| D-amino acid oxidase activity and expression are increased in schizophrenia. | Q43195422 | ||
| Spinal D-amino acid oxidase contributes to neuropathic pain in rats | Q43261398 | ||
| Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain | Q43291010 | ||
| The presence of free D-serine, D-alanine and D-proline in human plasma | Q43586675 | ||
| A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
| Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat. | Q44590316 | ||
| Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development | Q44609926 | ||
| The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure | Q44671940 | ||
| Unfolding intermediate in the peroxisomal flavoprotein D-amino acid oxidase. | Q44854761 | ||
| Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain | Q45780324 | ||
| Interference with cellular differentiation by D-serine through antagonism at N-methyl-D-aspartate receptors composed of NR1 and NR3A subunits in chondrocytes. | Q46006266 | ||
| Intracerebroventricular injection of L-proline and D-proline induces sedative and hypnotic effects by different mechanisms under an acute stressful condition in chicks | Q46235042 | ||
| Inhibition of cystathionine-beta-synthase activity during renal ischemia-reperfusion: role of pH and nitric oxide | Q46430945 | ||
| Synthesis and biological evaluation of D-amino acid oxidase inhibitors. | Q46572073 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 55 | |
| P577 | publication date | 2018-06-12 | |
| P1433 | published in | Frontiers in molecular biosciences | Q27726420 |
| P1476 | title | Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies | |
| P478 | volume | 5 |
| Q92071794 | Antibacterial Properties of D-Amino Acid Oxidase: Impact on the Food Industry |
| Q91716765 | CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway |
| Q59805075 | Human D-Amino Acid Oxidase: Structure, Function, and Regulation |
| Q102206214 | Winter is coming: Regulation of cellular metabolism by enzyme polymerization in dormancy and disease |
| Q90231367 | d-amino Acids in Health and Disease: A Focus on Cancer |
Search more.